glp 1 news Alarming rise in weight loss drug overdoses Could Weight Loss GLP-1 Drugs
Description
The meta-analysis further broke down how common nausea is for the five FDA-approved GLP-1 drug types, and another study looked at tirzepatides rate: Dulaglutide: 5-29% Exenatide: 5-59% Liraglutide: 10-48% Lixisenatide: 16-40% Semaglutide: 8-58% Tirzepatide: 20.43% Youll notice that these percentages vary quite a bit

Monitor blood glucose during episodes to rule out hypoglycemia

Intermittent fasting may increase the risk of hypoglycemia in individuals with type 2 diabetes on hypoglycemic agents and those with type 1 diabetes [289,290]

These stories help normalize the experiencepatients are not alone, and there are options for support

Week 1-4: 0.25 mg once weekly Weeks 5-8: 0.5 mg once weekly Weeks 9-12 (if needed): 1 mg once weekly, if further glycemic control is required Week 13 onwards (if needed): 2 mg once weekly, if your body can tolerate the previous dosage and further glycemic control is required This medication is started at 0.25 mg per week until you reach the maintenance dose
